14h
Pharmaceutical Technology on MSNGalderma enters fierce European atopic dermatitis market with Nemluvio approvalNemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...
1d
Zacks Investment Research on MSNLLY Rises More Than 4% in a Week: How to Play the StockEli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter ...
14hon MSN
Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit these popular categories the hardest.
We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund.
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
4d
MarketBeat on MSNThese Stocks Missed on Earnings, But Will Rebound Next QuarterBut over time, your decision to buy or sell a company’s stock should be based on what you believe will happen in the future.
2d
MarketBeat on MSNGLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss TrendsDetailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Doctors have begun noticing a trend among their colleagues: many have visibly shed pounds, and it's all thanks to drugs like ...
Resmed has its origins in the 1980s, when Sydney sleep expert Dr Colin Sullivan converted a vacuum cleaner to deal with the ...
Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results